Provided By GlobeNewswire
Last update: May 8, 2024
SOUTH SAN FRANCISCO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today reported financial results and recent highlights for the first quarter ended March 31, 2024.
Read more at globenewswire.comNASDAQ:ASMB (4/25/2025, 8:00:00 PM)
10.7
+0.17 (+1.61%)
Find more stocks in the Stock Screener